Valneva to conduct investor meetings during the j.p. morgan healthcare conference and oddo bhf forum

Saint-herblain (france), december 21, 2022 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announces that members of its management team including thomas lingelbach, ceo and peter bÜhler, cfo will hold investor meetings during the 41st annual j.p. morgan healthcare conference, january 9 – 12, 2023 in san francisco and the oddo bhf forum, january 5 - 6, 2023 in lyon france.
VALN Ratings Summary
VALN Quant Ranking